T 1648/23 of 22.05.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T164823.20240522
- Date of decision
- 22 May 2024
- Case number
- T 1648/23
- Petition for review of
- -
- Application number
- 12805432.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Binding molecules for BCMA and CD3
- Applicant name
- Amgen Research (Munich) GmbH
Amgen Inc. - Opponent name
- AbbVie Inc.
Janssen Biotech, Inc.
Regeneron Pharmaceuticals, Inc.
James Poole Limited
Mathys & Squire LLP
Sanofi - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Termination of the appeal proceedings - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.